Mario Thevis

Q: What Schools Are Affiliated With Mario Thevis

Mario Thevis is affiliated with the following schools: German Sport University Cologne, University of Cologne, University of California, Los Angeles

Mario Thevis's AcademicInfluence.com Rankings

Mario Thevis

Philosophy

#8207

World Rank

#11542

Historical Rank

Logic

#5237

World Rank

#6621

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Mario Thevis's Degrees

PhD Sports Science University of Cologne
Masters Sports Science University of Cologne
Bachelors Sports Science University of Cologne

Why Is Mario Thevis Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mario Thevis's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nutritional supplements cross-contaminated and faked with doping substances. (2008) (328)
Factors influencing the steroid profile in doping control analysis. (2008) (229)
Δ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids (2008) (199)
Mass spectrometry in sports drug testing: Structure characterization and analytical assays. (2007) (168)
Determination of 13C/12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes. (2008) (154)
RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability (2013) (143)
In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 (2010) (142)
Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer (2012) (132)
Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. (2011) (129)
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. (2005) (129)
Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine. (2006) (113)
Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. (2008) (102)
Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. (2003) (99)
Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. (2005) (99)
Current role of LC-MS(/MS) in doping control (2007) (97)
Mass spectrometric determination of insulins and their degradation products in sports drug testing. (2008) (96)
Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. (2010) (95)
Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. (2008) (92)
Anabolic agents: recent strategies for their detection and protection from inadvertent doping (2014) (90)
Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. (2003) (89)
Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. (2006) (88)
Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. (2012) (83)
Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1 -/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation (2007) (83)
Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry (2011) (82)
Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. (2014) (79)
Aryl-Propionamide-Derived Selective Androgen Receptor Modulators: Liquid Chromatography-Tandem Mass Spectrometry Characterization of the in Vitro Synthesized Metabolites for Doping Control Purposes (2008) (77)
Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. (2006) (77)
Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. (2012) (76)
Sports drug testing using complementary matrices: Advantages and limitations. (2016) (74)
Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. (2009) (74)
Identification of black market products and potential doping agents in Germany 2010–2013 (2014) (73)
Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. (2007) (73)
Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. (2005) (72)
High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach. (2011) (71)
Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing (2011) (69)
Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers. (2005) (68)
Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry (2012) (67)
Different mechanical loading protocols influence serum cartilage oligomeric matrix protein levels in young healthy humans (2010) (66)
Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing (2012) (63)
Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. (2008) (63)
Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches. (2008) (63)
High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. (2001) (62)
Obesity resistance and deregulation of lipogenesis in Δ6‐fatty acid desaturase (FADS2) deficiency (2014) (61)
Clenbuterol - regional food contamination a possible source for inadvertent doping in sports. (2012) (61)
Evaluation of commercially available assays for the measurement of equine insulin. (2011) (61)
New potential markers for the detection of boldenone misuse (2012) (60)
Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. (2013) (59)
Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. (2012) (59)
Anabolic, doping, and lifestyle drugs, and selected metabolites in wastewater—detection, quantification, and behaviour monitored by high-resolution MS and MSn before and after sewage treatment (2010) (58)
Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. (2010) (58)
Comprehensive plasma-screening for known and unknown substances in doping controls. (2010) (58)
Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. (2013) (57)
Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. (2009) (57)
Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins. (2005) (57)
Urinary concentrations of morphine and codeine after consumption of poppy seeds. (2003) (56)
Mass spectrometry of selective androgen receptor modulators. (2008) (55)
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis. (2009) (55)
Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry. (2006) (55)
Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. (2011) (53)
Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing (2013) (52)
Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison. (2008) (52)
Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS). (2014) (52)
Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays (2010) (51)
Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. (2011) (49)
Long‐term engraftment following transplantation of pig pancreatic primordia into non‐immunosuppressed diabetic rhesus macaques (2007) (48)
Annual banned-substance review: analytical approaches in human sports drug testing. (2012) (48)
Detection of SARMs in doping control analysis (2017) (47)
Use of dried blood spots in doping control analysis of anabolic steroid esters. (2014) (47)
Proteases in doping control analysis. (2007) (47)
Determination of (13)C/(12)C ratios of endogenous urinary steroids excreted as sulpho conjugates. (2010) (46)
Application of FAIMS to anabolic androgenic steroids in sport drug testing. (2009) (46)
Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of eleven anabolic steroid metabolites (2008) (46)
Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry. (2006) (46)
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. (2014) (46)
Measuring insulin in human vitreous humour using LC-MS/MS. (2012) (45)
Mass spectrometric analysis of androstan-17β-ol-3-one and androstadiene-17β-ol-3-one isomers (2005) (44)
Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis. (2007) (44)
Metabolism of growth hormone releasing peptides. (2012) (44)
Identification of Fentanyl, Alfentanil, Sufentanil, Remifentanil and Their Major Metabolites in Human Urine by Liquid Chromatography/Tandem Mass Spectrometry for Doping Control Purposes (2005) (44)
Plasticizers excreted in urine: indication of autologous blood transfusion in sports (2012) (43)
Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? (2013) (43)
Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. (2007) (43)
Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. (2010) (42)
Dietary Supplement and Food Contaminations and Their Implications for Doping Controls (2020) (42)
Detection of the plasma volume expander hydroxyethyl starch in human urine. (2000) (42)
Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts (2012) (41)
Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training. (2020) (41)
“Dilute-and-inject” multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing (2015) (41)
Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry (2015) (41)
Doping control analysis of selected peptide hormones using LC-MS(/MS). (2011) (41)
Detection of manipulation in doping control urine sample collection: a multidisciplinary approach to determine identical urine samples (2007) (41)
Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations. (2013) (41)
New drugs and methods of doping and manipulation. (2008) (40)
Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry. (2006) (40)
Dried blood spots (DBS) for doping control analysis (2011) (40)
Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase (2009) (40)
Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite (2007) (40)
Identification of human pituitary growth hormone variants by mass spectrometry. (2009) (40)
Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC–MS/MS (2008) (40)
Annual banned-substance review: analytical approaches in human sports drug testing. (2010) (40)
Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. (2016) (40)
Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. (2011) (39)
Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. (2013) (38)
Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls (2010) (38)
Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. (2011) (38)
Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry. (2005) (37)
Detection of Surreptitious Administration of Analog Insulin to an 8-Week-Old Infant (2010) (37)
Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing (2011) (37)
Quantification of urinary AICAR concentrations as a matter of doping controls (2010) (37)
Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation. (2012) (36)
Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. (2009) (36)
Emerging drugs--potential for misuse in sport and doping control detection strategies. (2007) (36)
Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing. (2016) (36)
Investigations of the microbial transformation of cortisol to prednisolone in urine samples (2012) (36)
Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites (2007) (35)
Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. (2010) (35)
Detection of homologous blood transfusion. (2007) (35)
Stimulants and doping in sport. (2010) (34)
Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry (2008) (34)
Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing. (2007) (34)
Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators. (2010) (34)
Analytical challenges in the detection of peptide hormones for anti-doping purposes. (2012) (34)
SERMs and SARMs: Detection of their activities with yeast based bioassays (2010) (34)
Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry. (2017) (34)
Determination of N-Desmethyl- and N-Bisdesmethyl Metabolites of Sibutramine in Doping Control Analysis Using Liquid Chromatography-Tandem Mass Spectrometry (2006) (34)
Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry (2005) (34)
Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. (2011) (34)
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. (2016) (33)
Can dried blood spots (DBS) contribute to conducting comprehensive SARS‐CoV‐2 antibody tests? (2020) (33)
Mass spectrometric characterization of transferrins and their fragments derived by reduction of disulfide bonds (2003) (33)
Quantitative Analysis of Urinary Glycerol Levels for Doping Control Purposes Using Gas Chromatography-Mass Spectrometry (2008) (32)
Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway. (2018) (32)
Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. (2008) (32)
Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. (2015) (32)
Temporal indication of cannabis use by means of THC glucuronide determination. (2009) (31)
Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503. (2009) (31)
Detection of His-tagged Long-R³-IGF-I in a black market product. (2010) (31)
Doping control analysis of trenbolone and related compounds using liquid chromatography–tandem mass spectrometry (2009) (31)
Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS. (2003) (31)
Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015 (2014) (31)
Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing. (2008) (30)
Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes (2016) (30)
Annual banned-substance review: Analytical approaches in human sports drug testing. (2018) (30)
Detection of Stanozolol and Its Major Metabolites in Human Urine by Liquid Chromatography-Tandem Mass Spectrometry (2006) (30)
Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. (2013) (30)
Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry. (2011) (30)
Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry. (2017) (29)
Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes. (2011) (29)
Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone (2008) (29)
Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs. (2016) (29)
Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience. (2010) (29)
Human sports drug testing by mass spectrometry. (2017) (29)
Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing (2013) (29)
Mass spectrometry of hydantoin-derived selective androgen receptor modulators. (2008) (29)
Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability. (2016) (28)
Identification of steroid isoxazole isomers marketed as designer supplement (2009) (28)
Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept. (2012) (28)
17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. (2006) (28)
Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. (2006) (28)
Mass spectrometric identification of peptide hormones in doping-control analysis. (2007) (28)
Use of an Electrochemically Synthesised Metabolite of a Selective Androgen Receptor Modulator for Mass Spectrometry-Based Sports Drug Testing (2008) (27)
Detection of testosterone esters in blood. (2015) (27)
In-gel derivatization of proteins for cysteine-specific cleavages and their analysis by mass spectrometry. (2003) (27)
Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes. (2009) (27)
Screening for Two Selective Androgen Receptor Modulators Using Gas Chromatography-Mass Spectrometry in Doping Control Analysis (2008) (27)
Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS (2020) (27)
Detection of Dehydroepiandrosterone Misuse by Means of Gas Chromatography-Combustion-Isotope Ratio Mass Spectrometry (2007) (27)
Annual banned-substance review: analytical approaches in human sports drug testing. (2011) (27)
Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing. (2015) (27)
Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation (2008) (26)
Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes. (2015) (26)
Rapid screening of polysaccharide-based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography-tandem mass spectrometry. (2008) (26)
Mass spectrometry of steroid glucuronide conjugates. I. Electron impact fragmentation of 5alpha-/5beta-androstan-3alpha-ol-17-one glucuronides, 5alpha-estran-3alpha-ol-17-one glucuronide and deuterium-labelled analogues. (2001) (26)
Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. (2015) (26)
Current role of LC–MS(/MS) in doping control (2007) (26)
Effects of endurance exercise on the urinary proteome analyzed by 2‐D PAGE and Orbitrap MS (2010) (25)
Identification and quantification of the plasma volume expander dextran in human urine by liquid chromatography-tandem mass spectrometry of enzymatically derived isomaltose. (2005) (25)
Quantifying cobalt in doping control urine samples--a pilot study. (2014) (25)
Electrospray ionization mass spectrometric characterization and quantitation of xanthine derivatives using isotopically labelled analogues: an application for equine doping control analysis. (2004) (25)
Zeranol: doping offence or mycotoxin? A case-related study. (2011) (25)
Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis (2013) (25)
Nutrition Status of Young Elite Female German Football Players. (2017) (25)
Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry (2010) (24)
Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS (2016) (24)
Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. (2011) (24)
Screening of In Vitro Synthesised Metabolites of 4,9,11-Trien-3-One Steroids by Liquid Chromatography-Mass Spectrometry (2008) (24)
Mass spectrometric behavior of thiazide-based diuretics after electrospray ionization and collision-induced dissociation. (2002) (24)
Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). (2019) (24)
Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing. (2013) (24)
Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry. (2018) (24)
Metabolism of Oral Turinabol by Human Steroid Hormone–Synthesizing Cytochrome P450 Enzymes (2016) (24)
Proteolysis and autolysis of proteases and the detection of degradation products in doping control. (2009) (24)
Analytical Approaches in Human Sports Drug Testing - Recent Advances, Challenges, and Solutions. (2020) (23)
Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border (2017) (23)
Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes. (2006) (23)
Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection. (2012) (23)
Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry. (2014) (23)
Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath (2017) (23)
Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination. (2016) (23)
Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. (2012) (22)
Validated hemoglobin‐depletion approach for red blood cell lysate proteome analysis by means of 2D PAGE and Orbitrap MS (2012) (22)
Determination of Synacthen® in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry (2015) (22)
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions (2014) (22)
Quantification of intact human insulin-like growth factor-I in serum by nano-ultrahigh-performance liquid chromatography/tandem mass spectrometry. (2014) (22)
Pharmacokinetics of altrenogest in horses. (2007) (21)
Quantitative Determination of Adrenaline and Noradrenaline in Urine Using Liquid Chromatography-Tandem Mass Spectrometry (2006) (21)
Dietary ω3-and ω6-Polyunsaturated fatty acids reconstitute fertility of Juvenile and adult Fads2-Deficient mice (2020) (21)
Determination of ¹³C/¹² C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1β-D-ribofuranoside (AICAR). (2014) (21)
Metabolism of human insulin after subcutaneous administration: A possible means to uncover insulin misuse. (2015) (21)
Targeting prohibited substances in doping control blood samples by means of chromatographic–mass spectrometric methods (2013) (21)
Annual banned-substance review: analytical approaches in human sports drug testing. (2016) (21)
Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis. (2005) (21)
Structure Elucidation of the Diagnostic Product Ion at m/z 97 Derived from Androst-4-en-3-One-Based Steroids by ESI-CID and IRMPD Spectroscopy (2012) (21)
Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS (2013) (20)
Determination of stimulants using gas chromatography/high-resolution time-of-flight mass spectrometry and a soft ionization source. (2012) (20)
Erythropoietic effects of low-dose cobalt application. (2018) (20)
Simplified quantification of insulin, its synthetic analogues and C-peptide in human plasma by means of LC-HRMS. (2020) (20)
Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? (2020) (20)
Determination of Selected Stimulants in Urine for Sports Drug Analysis by Solid Phase Extraction via Cation Exchange and Means of Liquid Chromatography-Tandem Mass Spectrometry (2008) (20)
The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs) (2013) (20)
Mass spectrometry of partially methylated alditol acetates derived from hydroxyethyl starch. (2000) (20)
Mass spectrometric detection of siRNA in plasma samples for doping control purposes (2010) (20)
Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry-a pilot study. (2009) (20)
Storage‐induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high‐resolution/high‐accuracy MS (2012) (19)
GHB-O-β-glucuronide in blood and urine is not a suitable tool for the extension of the detection window after GHB intake (2017) (19)
Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105. (2013) (19)
Solutions Advertised as Erythropoiesis-stimulating Products were Found to Contain Undeclared Cobalt and Nickel Species (2016) (19)
Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis (2021) (19)
Detection of recombinant growth hormone in human plasma by a 2‐D PAGE method (2008) (19)
Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review. (2018) (18)
Simultaneous determination of insulin, DesB30 insulin, proinsulin, and C-peptide in human plasma samples by liquid chromatography coupled to high resolution mass spectrometry (2016) (18)
Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes. (2014) (18)
Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature. (2007) (18)
Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry. (2006) (18)
Mass spectrometry of steroid glucuronide conjugates. II-Electron impact fragmentation of 3-keto-4-en- and 3-keto-5alpha-steroid-17-O-beta glucuronides and 5alpha-steroid-3alpha,17beta-diol 3- and 17-glucuronides. (2001) (18)
Challenges in Modern Anti-Doping Analytical Science. (2017) (18)
Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS. (2016) (18)
Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits (2014) (18)
Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone. (2018) (18)
Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS. (2009) (17)
Annual banned-substance review-analytical approaches in human sports drug testing. (2019) (17)
GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity. (2007) (17)
Effect of the location of hydrogen abstraction on the fragmentation of diuretics in negative electrospray ionization mass spectrometry (2003) (17)
The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration. (2008) (17)
Organ distribution of 4-MEC, MDPV, methoxetamine and α-PVP: comparison of QuEChERS and SPE (2018) (17)
Annual banned-substance review-analytical approaches in human sports drug testing 2019/2020. (2020) (17)
Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry. (2016) (17)
Identification of fibroblast growth factor 1 (FGF-1) in a black market product. (2011) (17)
Recent advances in the determination of insulins from biological fluids. (2019) (17)
Determination of Tuaminoheptane in Doping Control Urine Samples (2007) (17)
Prevalence of antidepressants and biosimilars in elite sport. (2009) (17)
Effects of exercise on the urinary proteome. (2015) (16)
Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications (2017) (16)
Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection. (2017) (16)
Urinary excretion of exogenous glycerol administration at rest. (2011) (16)
Mass spectrometry-based analysis of IGF-1 and hGH. (2010) (16)
Analysis of octopamine in human doping control samples. (2012) (16)
Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation (2018) (16)
Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. (2013) (16)
Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes. (2019) (15)
Mapping the interaction of cofilin with subdomain 2 on actin. (2007) (15)
Seizures of doping substances at the Swiss Border--a descriptive investigation. (2015) (15)
Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis. (2009) (15)
Isolation, enrichment, and analysis of erythropoietins in anti-doping analysis by receptor-coated magnetic beads and liquid chromatography-mass spectrometry. (2014) (15)
Annual banned-substance review: the Prohibited List 2008-analytical approaches in human sports drug testing. (2009) (15)
Dried blood spots (DBS) in doping controls: a complementary matrix for improved in- and out-of-competition sports drug testing strategies (2015) (15)
Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis. (2015) (15)
Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry (2016) (15)
Mass spectrometric detection of peginesatide in human urine in doping control analysis. (2012) (15)
lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls. (2017) (15)
QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY (2006) (14)
Equine in vivo-derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites. (2018) (14)
Identification and Quantification of the Osmodiuretic Mannitol in Urine for Sports Drug Testing Using Gas Chromatography-Mass Spectrometry (2008) (14)
Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control. (2018) (14)
Glycerol administration before endurance exercise: metabolism, urinary glycerol excretion and effects on doping-relevant blood parameters. (2014) (14)
Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis (2016) (14)
Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass spectrometry. (2008) (14)
Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. (2011) (14)
Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes. (2017) (14)
Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine. (2016) (14)
Urine analysis concerning xenon for doping control purposes. (2015) (13)
Development of two complementary LC-HRMS methods for analyzing sotatercept in dried blood spots for doping controls. (2019) (13)
Detection of an unknown fusion protein in confiscated black market products. (2014) (13)
Applications of Isotope Ratio Mass Spectrometry in Sports Drug Testing Accounting for Isotope Fractionation in Analysis of Biological Samples. (2017) (13)
Studies on the in vivo metabolism of Methylstenbolone and detection of novel long term metabolites for doping control analysis. (2019) (13)
Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. (2013) (13)
Liquid Chromatography-High Resolution/High Accuracy (Tandem) Mass Spectrometry-Based Identification of in vivo Generated Metabolites of the Selective Androgen Receptor Modulator ACP-105 for Doping Control Purposes (2014) (13)
In vitro Metabolism Studies on the Selective Androgen Receptor Modulator LG121071 and its Implementation into Human Doping Controls Using Liquid Chromatography-Mass Spectrometry (2015) (13)
RNA interference for performance enhancement and detection in doping control. (2011) (13)
Characterization of In Vitro Synthesized Equine Metabolites of the Selective Androgen Receptor Modulators S24 and S4 (2012) (13)
Annual banned-substance review: Analytical approaches in human sports drug testing. (2019) (12)
Single-dose administration of clenbuterol is detectable in Dried Blood Spots. (2020) (12)
Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches. (2014) (12)
Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls. (2014) (12)
The atypical excretion profile of meldonium: Comparison of urinary detection windows after single‐ and multiple‐dose application in healthy volunteers (2017) (12)
Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls. (2013) (12)
Antibody-based strategies for the detection of Luspatercept (ACE-536) in human serum. (2017) (12)
Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls. (2018) (12)
Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine. (2019) (11)
Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS. (2018) (11)
Inter-Laboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured Intact by Mass Spectrometry. (2020) (11)
Identification of Selected in vitro-Generated Phase-I Metabolites of the Steroidal Selective Androgen Receptor Modulator MK-0773 for Doping Control Purposes (2016) (11)
Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication (2018) (11)
Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS--a pilot study. (2013) (11)
N-methyl-N-Trimethylsilyltrifluoroacetamide-Promoted Synthesis and Mass Spectrometric Characterization of Deuterated Ephedrines (2004) (11)
Posttranslational hydroxylation of human phenylalanine hydroxylase is a novel example of enzyme self-repair within the second coordination sphere of catalytic iron. (2003) (11)
Detection of the protease bacillolysin in doping-control urine samples. (2009) (11)
Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. (2019) (11)
Investigation of the metabolites of the HIF stabilizer FG‐4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry (2017) (11)
Development and validation of a multidimensional gas chromatography/combustion/isotope ratio mass spectrometry-based test method for analyzing urinary steroids in doping controls. (2018) (11)
Paper spray mass spectrometry - A potential complementary technique for the detection of polar compounds in sports drug testing. (2020) (11)
Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing. (2013) (10)
Detection and pharmacokinetics of tetrahydrogestrinone in horses. (2009) (10)
Analysis of new growth promoting black market products. (2018) (10)
Identification and characterization of in vitro and in vivo generated metabolites of the adiponectin receptor agonists AdipoRon and 112254. (2016) (10)
Analytical challenges in sports drug testing (2018) (10)
Annual banned-substance review: analytical approaches in human sports drug testing. (2017) (10)
Screening for benfluorex and its major urinary metabolites in routine doping controls (2011) (10)
Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls. (2017) (10)
Meta-analysis: Effects of glycerol administration on plasma volume, haemoglobin, and haematocrit. (2013) (10)
In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples (2019) (10)
Detection of the Human Anti‐ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC‐HRMS (2018) (10)
SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins. (2018) (10)
Annual banned-substance review -analytical approaches in human sports drug testing 2020/2021. (2021) (10)
Effects of 3 Weeks of Oral Low-Dose Cobalt on Hemoglobin Mass and Aerobic Performance (2018) (10)
Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls. (2016) (10)
Carbon isotope ratio analysis of steroids by high-temperature liquid chromatography-isotope ratio mass spectrometry. (2014) (10)
Organ-on-a-chip: Determine feasibility of a human liver microphysiological model to assess long-term steroid metabolites in sports drug testing. (2021) (10)
Differing Water Intake and Hydration Status in Three European Countries—A Day-to-Day Analysis (2019) (10)
Development and validation of a HPLC–QTOF-MS method for the determination of GHB-β-O-glucuronide and GHB-4-sulfate in plasma and urine (2016) (10)
Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and western single blotting. (2018) (9)
Drug Testing and Analysis' one‐year impact factor (2012) (9)
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis (2021) (9)
Sports Drug Testing and the Athletes' Exposome. (2021) (9)
Mass Spectrometry-Based Characterization of New Drugs and Methods of Performance Manipulation in Doping Control Analysis (2010) (9)
Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS. (2020) (9)
Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes. (2014) (9)
Comprar Mass Spectrometry In Sports Drug Testing: Characterization Of Prohibited Substances And Doping Control Analytical Assays | M. Thevis | 9780470413272 | Wiley (2010) (9)
Detection of the myostatin-neutralizing antibody Domagrozumab in serum by means of Western blotting and LC-HRMS. (2019) (9)
Growth hormone isoform-differential mass spectrometry for doping control purposes. (2018) (9)
Acute hypertrophic but not maximal strength loading transiently enhances the kynurenine pathway towards kynurenic acid (2020) (9)
Mitragynine (Kratom) - monitoring in sports drug testing. (2016) (9)
Xenon elimination kinetics following brief exposure. (2017) (9)
Elimination profiles of microdosed ostarine mimicking contaminated products ingestion. (2020) (9)
Myostatin inhibitors in sports drug testing: Detection of myostatin‐neutralizing antibodies in plasma/serum by affinity purification and Western blotting (2016) (8)
Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation (2018) (8)
Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. (2021) (8)
Anti-doping analysis (2011) (8)
Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing. (2013) (8)
AOD-9604 does not influence the WADA hGH isoform immunoassay. (2013) (8)
Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control. (2009) (8)
Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO. (2013) (8)
Mass spectrometric studies on the in vitro generated metabolites of SIRT1 activating drugs for doping control purposes. (2013) (8)
Doping Control Analysis of Methoxyphenamine Using Liquid Chromatography-Tandem Mass Spectrometry (2008) (8)
Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports. (2017) (8)
Preliminary data on the potential for unintentional anti-doping rule violations by permitted CBD use. (2020) (8)
Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysis. (2016) (7)
Current Insights into the Steroidal Module of the Athlete Biological Passport (2021) (7)
Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing. (2021) (7)
Mass spectrometry in sports drug testing (2014) (7)
Effects of gamma irradiation and 15 days of subsequent ex vivo storage on the cytosolic red blood cell proteome analyzed by 2D‐DIGE and Orbitrap MS (2013) (7)
Updated protocols for the detection of Sotatercept and Luspatercept in human serum. (2018) (7)
Doping Control Analysis of Metamfepramone and Two Major Metabolites Using Liquid Chromatography-Tandem Mass Spectrometry (2009) (7)
Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? (2019) (7)
Elevated urinary cobalt concentrations identified in routine doping controls can originate from vitamin B12. (2019) (7)
First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy (2021) (7)
Effect of Acute and Chronic Xenon Inhalation on Erythropoietin, Hematological Parameters, and Athletic Performance. (2019) (7)
Mass spectrometric analysis of androstan-17beta-ol-3-one and androstadiene-17beta-ol-3-one isomers. (2005) (7)
Analysis of Major Isoforms of Human Growth Hormone before and after Intensive Physical Exercise (2008) (7)
Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS. (2017) (7)
EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS (2015) (7)
Implementation and performance of the gas chromatography/combustion/isotope ratio mass spectrometry-based method for the confirmatory analysis of endogenous anabolic steroids during the Rio de Janeiro Olympic and Paralympic Games 2016. (2019) (6)
Case Study: Atypical δ13 C values of urinary norandrosterone. (2018) (6)
Screening for adiponectin receptor agonists and their metabolites in urine and dried blood spots (2017) (6)
Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy (2019) (6)
Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations. (2017) (6)
Probing for corticotropin-releasing hormone (CRH) in human blood for doping control purposes using immunoaffinity purification and LC-HRMS/MS (2017) (6)
Fatalities associated with NPS stimulants in the Greater Cologne area (2019) (6)
Micronucleus induction in V79 cells by the anabolic doping steroids desoxymethyltestosterone (madol) and 19-norandrostenedione. (2008) (6)
Factitious administration of analogue insulin to a 2-year-old child (2015) (6)
Analysis of taxine B/isotaxine B in a plasma specimen by LC–MS/MS in a case of fatal poisoning: concealed suicide by ingestion of yew (Taxus L.) leaves of a patient with a long-term history of borderline personality disorder (2017) (6)
Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis. (2021) (6)
Identification of Trenbolone Metabolites Using Hydrogen Isotope Ratio Mass Spectrometry and Liquid Chromatography/High Accuracy/High Resolution Mass Spectrometry for Doping Control Analysis (2020) (6)
Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimers. (2010) (6)
Is heptaminol a (major) metabolite of octodrine? (2019) (6)
In vitro elucidation of the metabolic profile of the synthetic cannabinoid receptor agonists JWH-175 and JWH-176 (2016) (6)
Nickel in equine sports drug testing - pilot study results on urinary nickel concentrations. (2016) (6)
Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. (2015) (6)
Detection of Peginesatide in Equine Serum Using Liquid Chromatography-Tandem Mass Spectrometry for Doping Control Purposes (2012) (5)
Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry. (2012) (5)
Illicit organogenesis (2008) (5)
Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing. (2015) (5)
Peptidic drugs and drug candidates in sports drug testing: agents affecting mitochondrial biogenesis or preventing activin receptor II activation (2019) (5)
Mass Spectrometry and the List of Prohibited Substances and Methods of Doping (2010) (5)
Potency of Full- Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations (2016) (5)
First Steps toward Uncovering Gene Doping with CRISPR/Cas by Identifying SpCas9 in Plasma via HPLC-HRMS/MS. (2020) (5)
Facilitated Qualitative Determination of Insulin, Its Synthetic Analogs, and C-Peptide in Human Urine by Means of LC–HRMS (2021) (5)
Probing for the presence of doping agents in exhaled breath using chromatographic-mass spectrometric approaches. (2020) (5)
Tainted toothpaste - analytical investigation into an unusual adverse finding. (2020) (5)
Detection of follistatin-based inhibitors of the TGF-β signaling pathways in serum/plasma by means of LC-HRMS/MS & Western blotting. (2020) (5)
Effect of a Single Bout of Aerobic Exercise on Kynurenine Pathway Metabolites and Inflammatory Markers in Prostate Cancer Patients—A Pilot Randomized Controlled Trial (2020) (5)
Safety, hemodynamic effects and detection of acute xenon inhalation: Rationale for banning xenon from sport. (2019) (5)
Carbon isotope ratios of endogenous steroids found in human serum—method development, validation, and reference population-derived thresholds (2021) (5)
Detecting the misuse of 7-oxo-DHEA by means of carbon isotope ratio mass spectrometry in doping control analysis. (2020) (5)
Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis. (2014) (4)
Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing. (2015) (4)
Analysis of Low Molecular Weight Substances in Doping Control (2008) (4)
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes (2021) (4)
The Role of Mass Spectrometry for Peptide, Protein, and Proteome Characterization (2012) (4)
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]. (2009) (4)
Implementation of the HIF activator IOX-2 in routine doping controls - pilot study data. (2020) (4)
RECENT ADVANCES IN DOPING ANALYSES (2) (2007) (4)
Isolation and characterization of a β-glucuronide of hydroxylated SARM S1 produced using a combination of biotransformation and chemical oxidation. (2014) (4)
An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile. (2020) (4)
Annual banned-substance review: analytical approaches in human sports drug testing. (2014) (4)
In vitro synthesis and characterisation of three fenoterol sulfoconjugates detected in fenoterol post-administration urine samples (2013) (4)
Performance‐Enhancing Drugs (2009) (3)
Meldonium residues in milk: A possible scenario for inadvertent doping in sports? (2021) (3)
Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses. (2017) (3)
Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testing. (2012) (3)
Wiley‐Interscience Series in Mass Spectrometry (2010) (3)
Metabolism of “ new ” anabolic steroids : Development of in vitro methodology in metabolite production and analytical techniques (2007) (3)
Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol (2021) (3)
Probing for the presence of semenogelin in human urine by immunological and chromatographic‐mass spectrometric methods in the context of sports drug testing (2021) (3)
Determination of ghrelin and desacyl ghrelin in human plasma and urine by means of LC-MS/MS for doping controls. (2021) (3)
Annual banned-substance review: analytical approaches in human sports drug testing. (2015) (3)
Urinary Excretion Of Exogenous Glycerol Administered Before Endurance Exercise: 2982 (2011) (3)
Detection of Black Market Follistatin 344. (2019) (3)
Effects of different exercise intensities in the morning on football performance components in the afternoon (2018) (3)
Identification of proteolytic enzymes in human urine (2008) (3)
Detection of anti‐SARS‐CoV‐2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA) (2021) (3)
Modern Mass Spectrometry‐Based Analytical Assays (2010) (3)
Analysis of endogenous steroids in urine by means of multi-immunoaffinity chromatography and isotope ratio mass spectrometry for sports drug testing (2019) (3)
Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency[S] (2019) (3)
Application of the Athlete Biological Passport approach to the detection of growth hormone doping. (2021) (3)
Comparison of hGH serum concentrations of Caucasian and African top athletes : an ethnicity study (2011) (2)
Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing (2013) (2)
Annual banned-substance review: analytical approaches in human sports drug testing. (2010) (2)
Mass spectrometric identification and characterization of a new long-term metabolite of metandienone (2006) (2)
Carbon isotope ratios of endogenous steroids in Belgian Blue and Holstein cattle: Method development, reference population studies and application to steroid misuse control. (2017) (2)
Chromatographic-mass spectrometric analysis of the urinary metabolite profile of chlorphenesin observed after dermal application of chlorphenesin-containing sunscreen. (2021) (2)
Detection of undeclared doping substances in nutritional supplements in the context of follow-up investigations concerning adverse analytical findings. (2021) (2)
New Sample Preparation Procedure for the Confirmation of Stanozolol and its Metabolites by Means of GC / MSMS and LC / ESI-MSMS (2007) (2)
Stereoisomers in sports drug testing: Analytical strategies and applications. (2022) (2)
Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats (2018) (2)
Mass spectrometric characterization of urinary hydrafinil metabolites for routine doping control purposes. (2021) (2)
Investigation of Equine In Vivo and In Vitro Derived Metabolites of the Selective Androgen Receptor Modulator (SARM) ACP-105 for Improved Doping Control (2021) (2)
Testosterone: Detection of illegal use of androgens and selective androgen receptor modulators (2012) (2)
Organic Chemistry of Drug Degradation. Authored by Min Li (2013) (2)
Response to Letter to the Editor regarding “Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing” (2011) (2)
Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models (2021) (2)
Analytik modifizierter Steroidhormone mittels Flüssigkeitschromatographie/Tandem-Massenspektrometrie Analysis of modified steroid hormones using liquid chromatography/tandem mass spectrometry (2006) (2)
Measurement of exogenous gamma-hydroxybutyric acid ( GHB ) in urine using isotope ratio mass spectrometry ( IRMS ) (2015) (2)
Broadening the Horizon of Antidoping Analytical Approaches Using Dried Blood Spots. (2021) (2)
Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples. (2019) (2)
Toxicology of Specific Substances (2014) (2)
DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing (2022) (2)
Structure Characterization of High Molecular Weight Target Analytes: Electrospray Ionization (2010) (1)
Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control. (2021) (1)
Probing for factors influencing exhaled breath drug testing in sports - pilot studies focusing on the tested individual's tobacco smoking habit and sex. (2022) (1)
Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication (2018) (1)
Identification and monitoring of octopamine sulfoconjugate in urine by LC / ( ESI )-MS / MS (2012) (1)
Annual banned-substance review -analytical approaches in human sports drug testing 2021/2022. (2022) (1)
Growth hormone: barriers to the implementation of human growth hormone testing in sport. Interview by Paul Trevorrow. (2009) (1)
Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry (2016) (1)
In vivo metabolism of Selective Androgen Receptor Modulators (SARMs) in the horse (2014) (1)
Using electrochemistry for metabolite simulation and synthesis in preventive doping research: application to the Rycal S107 and the PPARδ-agonist GW1516 (2013) (1)
In reply (2012) (1)
Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches. (2022) (1)
Excretion of 19-norandrosterone after consumption of boar meat. (2020) (1)
The 33rd Manfred Donike Workshop on Doping Analysis. (2015) (1)
Comprehensive insights into the formation of metabolites of the ghrelin mimetics capromorelin, macimorelin and tabimorelin as potential markers for doping control purposes. (2021) (1)
OR07-3 Measurement of serum IGF-1 by LC-MS-MS: A multi-site validation study for anti-doping testing (2012) (1)
Synthesis of Four SIRT1 Activators Based on an Imidazo(1,2-b)thiazole Structure, in vitro Derived Metabolites and Deuterated Analogs (2014) (1)
The 36th Manfred Donike workshop on doping analysis. (2018) (1)
Detection of black market follistatin 344. (2020) (1)
Mass spectrometric study of the metabolism of Selective Androgen Receptor Modulators (SARMs) in the fungus Cunninghamella elegans (2012) (1)
Data from a microdosed rhEPO administration study applying the new biotinylated clone AE7A5 antibody and a further optimized SAR-PAGE protocol. (2021) (1)
Androgens, sports, and detection strategies for anabolic drug use. (2021) (1)
Depletion of clomiphene residues in eggs and muscle after oral administration to laying hens (2021) (1)
History of Sports Drug Testing (2010) (1)
Could Nickel Become a Novel Erythropoiesis-Stimulating Compound for Cheating Athletes? (2016) (1)
Investigation about the effects and the detection of finasteride, a substance which can be misused as masking agent in doping control (2006) (1)
Determination and enantioselective separation of zilpaterol in human urine after mimicking consumption of contaminated meat by HPLC-MS/MS techniques. (2022) (1)
Screening for Anastrozole in Doping Analysis (2006) (1)
Sensitive detection of testosterone and testosterone prohormone administrations based on urinary concentrations and carbon isotope ratios of androsterone and etiocholanolone. (2021) (1)
Chiral analysis of selected enantiomeric drugs relevant in doping controls (2021) (1)
Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control. (2016) (1)
Impact of recent biochemical findings on the determination of free and bioavailable testosterone: evaluation and proposal for clinical use / Auswirkungen neuer biochemischer Befunde auf die Bestimmung von freiem und bioverfügbarem Testosteron: Evaluierung und Vorschlag für den klinischen Einsatz (2006) (1)
Investigations in carbon isotope ratios of seized testosterone and boldenone preparations. (2021) (1)
Analysis of dried blood spots is a feasible alternative for detecting ephedrine in doping control. (2022) (1)
Risk of unintentional antidoping rule violations by consumption of hemp products. (2022) (1)
The 35th Manfred Donike workshop on doping analysis. (2017) (1)
Guest Editorial (2008) (0)
Enzyme-assisted synthesis and characterization of benzodiazepine glucuro-nides (2008) (0)
Hypoxia-inducible factor ( HIF ) pathway as target for doping purposes and mass spectrometric characterisation of orally available model HIF-stabilizers (2010) (0)
Effects of different exercise intensities in the morning on football performance components in the afternoon (2018) (0)
Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application. (2022) (0)
The human mitochondrial cytochromes P450 CYP11A1, CYP11B1 and CYP11B2 are involved in the biosynthesis of steroid hormones. CYP11A1 catalyzes the side-chain cleavage of cholesterol and CYP11B1 and CYP11B2 catalyze the final steps in the biosynthesis of gluco- (2015) (0)
Long-acting octreotide (Sandostatin LAR®) causes marked and sustained decrease in total and acyl ghrelin concentrations in adolescents with Prader-Willi Syndrome (2007) (0)
Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals (2023) (0)
Gender Differences In COPD And New Potential Biomarkers For Diagnosis By Proteomics Analysis (2012) (0)
Usefulness of serum androgen isotope ratio mass spectrometry (IRMS) to detect testosterone supplementation in women. (2022) (0)
A Targeted Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification of Peptides from the Carboxyl-terminal Region of Type III Procollagen, Biomarkers of Collagen Turnover. (2022) (0)
Qualitative determination of synthetic insulin analogues in human plasma by means of LC-MS / MS (2006) (0)
19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF (2015) (0)
Response to letter to the editor: "Comments on Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone". (2018) (0)
Contents: Proteomics 2'16. (2016) (0)
[Doping control activities in Germany 1989-2006]. (2008) (0)
The 39th Manfred Donike workshop on doping analysis. (2021) (0)
Qualitative determination of rapid acting insulin analogues in urine by means of LC-MS / MS (2007) (0)
Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome. (2022) (0)
Limitations and Perspectives of Mass Spectrometry‐Based Procedures in Doping Control Analysis (2010) (0)
ELEVATION OF SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) LEVEL DEPENDS ON LOADING MODE OF PHYSICAL ACTIVITY – PRELIMINARY RESULTS (2008) (0)
Identification of black market products and potential doping agents in Germany 2010–2013 (2014) (0)
Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes (2022) (0)
Investigations on storage-induced changes of the red blood cell lipidome (2014) (0)
Hugh L.J. Makin, David B. Gower (Eds.): Steroid analysis, 2nd ed. (2011) (0)
Mass spectrometry in drug metabolism and pharmacokineticx Ragu Ramanathan, Editor (2009) (0)
The 38th Manfred Donike workshop on doping analysis. (2020) (0)
Increased Normalcy Rate with Computed Tomography Attenuation Correction in Single Positron Emission Computed Tomography Myocardial Perfusion Imaging – Is it Useful ? (2016) (0)
SAT0219 Methotrexate-Induced Reduction in Concentration of HBA1C in Rheumatoid and Psoriatic Arthritis is Not Correlated with Sustained Increase in Erythrocyte ZMP or Urinary Aicar Concentration (2015) (0)
Investigations into the In Vitro Metabolism of hGH and IGF-I Employing Stable-Isotope-Labelled Drugs and Monitoring Diagnostic Immonium Ions by High-Resolution/High-Accuracy Mass Spectrometry (2022) (0)
Identification and determination of degradation products of human insulin and its long acting synthetic analogues in urine by means of ESI-LC-MS / MS (2008) (0)
Relative mobility values for the discrimination of endogenous and recombinant EPO on SDS gels (2009) (0)
Investigations on the in vivo metabolism of 5α-androst-2-en-17-one. (2022) (0)
Detection of proteases and their proteolysis and autolysis products in urine by LC-MS (2010) (0)
Direct Quantification of Salbutamol in Human Urine by Means of LC-MS / MS (2008) (0)
Characterization of a Selective Androgen Receptor Modulator Drug Candidate and Identification of In Vitro Generated Metabolites for Sports Drug Testing (2015) (0)
Quantification of 25-hydroxyvitamin D2 and D3 in Mitra® devices with volumetric absorptive microsampling technology (VAMS®) by UHPLC-HRMS for regular vitamin D status monitoring. (2023) (0)
How to detect CRISPR with CRISPR - employing SHERLOCK for doping control purposes. (2022) (0)
Drug glucuronides synthesized using a new concept combining Cunninghamella elegans with TEMPO (2013) (0)
Detection and method validation of peginesatide in human serum by means of LC-MS/MS (2013) (0)
Turning drug glucosides into glucuronides - making fungal incubations work together with chemical derivatization (2013) (0)
Myostatin inhibitory peptides in sports drug testing. (2023) (0)
GC-MS-IRMS : Undisputable results by coupling of GC-IRMS with high-resolution mass spectrometry for final confirmation in sports drug testing APPLICATION NOTE 30405 (2017) (0)
Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure ionization-mass spectrometry (2008) (0)
The 37th Manfred Donike Workshop on Doping Analysis. (2019) (0)
Sport doping detection in focus: A perspective from Prof. Dr Mario Thevis (2020) (0)
The 40th Manfred Donike workshop on doping analysis. (2022) (0)
Safety, Detection and Hemodynamic Effects of Acute Xenon Inhalation: Implications for Athletic Doping Practices (2017) (0)
In-vitro metabolis m selective androgen receptor modulators. [Conference poster]. (2012) (0)
Glycerol as prohibited substance: meta-analysis on the effects of glycerol administration on haemoglobin, haematocrit and plasma volume (2013) (0)
The 34th Manfred Donike Workshop on Doping Analysis. (2016) (0)
Electrophoretic Detection of Black Market Myostatin Propeptide. (2022) (0)
Hormone abuse in sports: the knowns and unknowns (2012) (0)
Detection of dehydroepiandrosterone misusey means of gas chromatography-comustion-isotope ratio mass spectrometry (2007) (0)
Acute hypertrophic but not maximal strength loading transiently enhances the kynurenine pathway towards kynurenic acid (2020) (0)
V 01 In vitro THC degradation by the skin colonising yeast Malassezia furfur (2017) (0)
Special issue-murders by drugs. (2009) (0)
AICAr to SAICAr ratio can serve as additional marker of AICAr use. (2022) (0)
Analysis of New Chemical Entities in a Sport Context (2021) (0)
Several possible toxicological and genetic tools for the extension of the detection window after GHB intake (2017) (0)
Mass spectrometric identification of human pituitary growth hormone variants (2008) (0)
XIX. GTFCh-Symposium Vorträge V01 An albumin adduct with the chemical warfare agent sulfur mustard detected by LC-ESI MS/MS: a novel method for verification of poisoning (2015) (0)
Addressing recent challenges in isotope ratio mass spectrometry: Development of a method applicable to 1-androstene-steroids, 6α-hydroxy-androstenedione and androstatrienedione. (2022) (0)
Mass Spectrometry in Sports Drug Testing : Detection of New Anabolic and Endurance Enhancing Agents (2009) (0)
Development of mass spectrometry-based methods for the detection of 11-ketotestosterone and 11-ketodihydrotestosterone. (2023) (0)
Structure Characterization of Low Molecular Weight Target Analytes—Electron Ionization (2010) (0)
In-vitro metabolism of GW1516 and implementation of its major metabolites in routine doping controls (2011) (0)
Urinary phenylethylamine metabolites as potential markers for sports drug testing purposes. (2021) (0)
Validation of a GC / MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis (2010) (0)
Mass spectrometric identification and characterization of urinary metabolites of isopropylnorsynephrine for doping control purposes (2021) (0)
159-OR: Endocrine and Metabolic Counterregulation to Standardized Postprandial Hypoglycemia after Bariatric Surgery (2022) (0)
Dried Blood Spots for Doping Controls - Development of a comprehensive Initial Testing Procedure with fully automated sample preparation. (2023) (0)
Dried blood spots as option to monitor the anti-sars-cov-2 antibody response after infection or vaccination (2022) (0)
Control of a Sulfadoxine/Trimethoprim Combination in the competition horse: Elimination, Metabolism and Detection following an intravenous Administration. (2023) (0)
Metabolism of oral turinabol by the human brain cholesterol 24-hydroxylase CYP46A1 (2021) (0)
Preliminary results for the development of a peptide screening method by means of LC-MS / MS (2011) (0)
Probing for peptidic drugs (2–10 kDa) in doping control blood samples (2022) (0)
Quantification of SARMs S1, S4 and S22 and detection of their metabolites in equine plasma usning UHPLC-Q-TOF (2015) (0)
Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 3: LC-MS/MS-based peptide analysis for dried blood spot sampling time point estimation. (2023) (0)
Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry (2022) (0)
[Doping in sport]. (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mario Thevis?

Mario Thevis is affiliated with the following schools:

German Sport University Cologne
University of Cologne
University of California, Los Angeles